Neuronetics, Inc. (STIM) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| NeuroStar Advanced Therapy System Revenue (United States) | 3.2M | FY2026-Q1 |
| NeuroStar Treatment Session Revenue (United States) | 9.12M | FY2026-Q1 |
| Revenue (International) | 228K | FY2026-Q1 |
| Revenue (United States) | 34.23M | FY2026-Q1 |
| Greenbrook Clinic Revenue (United States) | 21.53M | FY2026-Q1 |
| NeuroStar Advanced Therapy System Units Shipped (United States) | 34.00 | FY2026-Q1 |
| Other Revenue (United States) | 363K | FY2025-Q4 |
| NeuroStar Advanced Therapy System Systems Shipped | 49.00 | FY2025-Q4 |
| All-Time Patients Treated | 229.43K | FY2025-Q3 |
| All-Time Treatment Sessions | 8.2M | FY2025-Q3 |
Back to STIM overview · STIM earnings · STIM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.